Guangdong VTR Bio-Tech Co., Ltd. (300381.SZ)
CNY 7.27
(-0.41%)
CNY 7.27
(-0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 154.39 Million | 249.77 Million | 216.92 Million | 403.72 Million | 442.16 Million | 203.94 Million |
| Net Income | 1.15 Million | 37.52 Million | -85.42 Million | 202.33 Million | 170.44 Million | 150.58 Million |
| Depreciation & Amortization | 112.09 Million | 138.26 Million | 167.86 Million | 154.92 Million | 153.39 Million | 123.66 Million |
| Deferred income taxes | -3.52 Million | 7.68 Million | -19.78 Million | -844.78 Thousand | -5.9 Million | 6.42 Million |
| Stock-based compensation | 4.06 Million | 5.58 Million | 9.75 Million | - | - | - |
| Change in working capital | 31.64 Million | 190.56 Million | -76.81 Million | -21.64 Million | 30.31 Million | -186.49 Million |
| Other non-cash items | 9.04 Million | -116.58 Million | 211.31 Million | 68.1 Million | 88.01 Million | 116.19 Million |
| Investing Cash Flow | 142.21 Million | -411.31 Million | -254.53 Million | -311.36 Million | -466.1 Million | -148.14 Million |
| Investments in PPE | -394.16 Million | -197.78 Million | -162.97 Million | -283.04 Million | -397.9 Million | -311.09 Million |
| Acquisitions | 223.03 Thousand | 1.19 Billion | -91.15 Million | -11.8 Million | -77.72 Million | -15.08 Million |
| Investment purchases | -757.99 Million | -1.08 Billion | -20.08 Million | -14.33 Million | 407.32 Million | 488.07 Million |
| Sales/Maturities of investments | 897.67 Million | 378.31 Million | 19.66 Million | 13.8 Thousand | 112.37 Thousand | 1.04 Million |
| Other Investing Activities | 396.48 Million | -703.46 Million | 19.25 Thousand | -2.2 Million | -397.9 Million | -311.09 Million |
| Financing Cash Flow | -214.25 Million | 76.87 Million | 36.62 Million | -4.79 Million | -684.43 Million | 630.72 Million |
| Debt repayment | -25.65 Million | -709.83 Million | -816.46 Million | -824.5 Million | -1.34 Billion | -1.1 Billion |
| Dividends payments | -47.79 Million | -49 Million | -34.26 Million | -28.59 Million | -24.4 Million | -100.36 Million |
| Common Stock Repurchased | -39.06 Million | -61.05 Million | - | - | - | - |
| Common Stock Issuance | - | 61.05 Million | - | - | - | - |
| Other Financing Activities | -137.53 Million | 848.64 Million | 923.06 Million | 883.4 Million | 728.16 Million | 1.83 Billion |
| Accounts receivables | 27.66 Million | 154.07 Million | 11.83 Million | 11.91 Million | -116.68 Million | 121.1 Million |
| Accounts payables | -5.88 Million | 57.23 Million | -82.7 Million | -46.95 Million | 216.03 Million | -99.39 Million |
| Inventory | 13.39 Million | -28.42 Million | 13.83 Million | 14.23 Million | -63.13 Million | -214.62 Million |
| Other working capital | -9.41 Million | 7.68 Million | -19.78 Million | -844.78 Thousand | -5.9 Million | 28.12 Million |
| Cash at beginning of period | 169.09 Million | 251.67 Million | 252.98 Million | 164.87 Million | 873.27 Million | 188.08 Million |
| Cash at end of period | 252.06 Million | 169.09 Million | 251.67 Million | 252.98 Million | 164.87 Million | 873.27 Million |
| Capital Expenditure | -394.16 Million | -197.78 Million | -162.97 Million | -283.04 Million | -397.9 Million | -311.09 Million |
| Effect of forex changes on cash | 602.64 Thousand | 2.08 Million | -327.7 Thousand | 549.21 Thousand | -24.91 Thousand | -1.33 Million |
| Net cash flow / Change in cash | 82.96 Million | -82.58 Million | -1.3 Million | 88.11 Million | -708.39 Million | 685.19 Million |
| Free Cash Flow | -239.76 Million | 51.99 Million | 53.95 Million | 120.68 Million | 44.25 Million | -107.14 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.01 Million | 22.15 Million | 19.63 Million | -23.14 Million | 1.15 Million | 4.98 Million |
| Depreciation & Amortization | - | 28.56 Million | 28.56 Million | 112.09 Million | 112.09 Million | -53.59 Million |
| Deferred income taxes | - | - | - | - | -3.52 Million | - |
| Stock-based compensation | - | - | - | 4.06 Million | 4.06 Million | - |
| Change in working capital | - | -24.46 Million | - | 41.05 Million | 31.64 Million | 184.76 Million |
| Other non-cash items | 43.46 Million | 15.4 Million | 33.36 Million | -24.13 Million | 9.04 Million | -57.14 Million |
| Investing Cash Flow | -44.46 Million | -64.86 Million | -138.03 Million | -13.58 Million | 142.21 Million | 86.53 Million |
| Investments in PPE | -88.82 Million | -115.12 Million | -76.09 Million | -183.03 Million | -394.16 Million | -84.69 Million |
| Acquisitions | -163.73 Thousand | -9.5 Million | -80 Million | 4.05 Million | 223.03 Thousand | 26.1 Thousand |
| Investment purchases | - | - | -242 Million | -757.99 Million | -757.99 Million | 469.69 Million |
| Sales/Maturities of investments | 2.5 Million | -247.24 Million | 259.8 Million | 895.62 Million | 897.67 Million | -1.18 Million |
| Other Investing Activities | 42.02 Million | 64.99 Million | 18.06 Million | 27.79 Million | 396.48 Million | -297.29 Million |
| Financing Cash Flow | -21.79 Million | 54.54 Million | 144.81 Million | -3.03 Million | -214.25 Million | -120.1 Million |
| Debt repayment | -75.57 Thousand | -3.14 Million | -44 Million | -74.35 Million | -25.65 Million | -50 Million |
| Dividends payments | -3423.07 | -28.86 Million | - | -47.79 Million | -47.79 Million | -15.17 Million |
| Common Stock Repurchased | - | - | - | -39.06 Million | -39.06 Million | 39.05 Million |
| Common Stock Issuance | - | - | - | - | - | -39.05 Million |
| Other Financing Activities | -21.71 Million | 80.26 Million | 188.81 Million | -41.55 Million | -137.53 Million | -54.93 Million |
| Accounts receivables | - | 3.53 Million | - | 27.66 Million | 27.66 Million | 108.53 Million |
| Accounts payables | - | - | - | - | -5.88 Million | - |
| Inventory | - | -27.99 Million | - | 13.39 Million | 13.39 Million | 5.55 Million |
| Other working capital | - | - | - | - | - | 70.66 Million |
| Cash at beginning of period | 299.24 Million | 308.27 Million | 252.06 Million | 159.65 Million | 169.09 Million | 117.38 Million |
| Cash at end of period | 276.05 Million | 299.24 Million | 308.27 Million | 252.06 Million | 252.06 Million | 159.65 Million |
| Capital Expenditure | -88.82 Million | -115.12 Million | -76.09 Million | -183.03 Million | -394.16 Million | -84.69 Million |
| Effect of forex changes on cash | 1.08 Million | 2.03 Million | -3.56 Million | 3.16 Million | 602.64 Thousand | -4.35 Million |
| Net cash flow / Change in cash | -23.18 Million | -9.03 Million | 56.21 Million | 92.4 Million | 82.96 Million | 42.27 Million |
| Free Cash Flow | -44.34 Million | -106.13 Million | -23.09 Million | -77.17 Million | -239.76 Million | -5.67 Million |
CPYT
CCCP
UTGPF
002479
LIVE
KRSB